From October 30, 2021 to January 28, 2022, the company has repurchased 3,433,500 shares, representing 0.26% for $371.3 million. With this, the company has completed the repurchase of 67,667,007 shares, representing 5.02% for $6,649.18 million under the buyback announced on June 23, 2017.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
81.69 USD | +0.95% | +2.45% | -0.84% |
04-26 | Medtronic Receives FDA Approval for Inceptiv Spinal Cord Stimulator to Treat Chronic Pain | MT |
04-26 | Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.84% | 108B | |
-3.79% | 184B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B | |
-0.03% | 25.03B |
- Stock Market
- Equities
- MDT Stock
- News Medtronic plc
- Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017.